Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.1721
-0.0449 (-20.69%)
Oct 30, 2026, 1:23 PM EDT - Market open
SNTI Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -49.56 | -61.44 | -52.79 | -71.06 | -58.21 | -55.32 |
Depreciation & Amortization | 3.15 | 3.64 | 3.84 | 5.43 | 3.92 | 3.01 |
Loss (Gain) From Sale of Assets | - | - | - | -21.86 | - | - |
Asset Writedown & Restructuring Costs | 5.05 | 5.05 | 0.31 | 25.96 | - | 0.02 |
Loss (Gain) From Sale of Investments | - | - | - | -1.07 | -0.36 | - |
Stock-Based Compensation | 5.34 | 5.71 | 1.76 | 9.67 | 16.39 | 2.3 |
Other Operating Activities | -6.68 | 0.04 | -0.58 | -4.13 | -10.55 | 14.74 |
Change in Accounts Receivable | 3.14 | 0.21 | -0.71 | -0.93 | -0.13 | -0.4 |
Change in Accounts Payable | 1.25 | 1.74 | 0.8 | -0.29 | 0.19 | -0.62 |
Change in Unearned Revenue | 1.59 | -0.31 | -0.33 | -0.11 | -1.03 | 1.83 |
Change in Other Net Operating Assets | -1.33 | 1.92 | 6.32 | 5.99 | 14.88 | -0.21 |
Operating Cash Flow | -38.05 | -43.44 | -41.4 | -52.4 | -34.9 | -34.64 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.2 | -0.03 | -12.04 | -41.37 | -5.54 |
Sale of Property, Plant & Equipment | 0.11 | 0.01 | 0.06 | 0.11 | - | - |
Investment in Securities | - | - | - | 42.01 | -40.59 | - |
Investing Cash Flow | 0.11 | -0.18 | 0.03 | 30.08 | -81.96 | -5.54 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | - | - | - | 117.15 | - |
Total Debt Issued | 9.7 | - | - | - | 117.15 | - |
Long-Term Debt Repaid | - | - | - | -0.11 | - | -0.02 |
Net Debt Issued (Repaid) | 9.7 | - | - | -0.11 | 117.15 | -0.02 |
Issuance of Common Stock | 10.65 | 11.18 | 49.06 | 0.89 | 1.4 | 1.5 |
Other Financing Activities | 0.49 | 0.58 | 4.67 | - | - | - |
Financing Cash Flow | 20.72 | 11.76 | 53.73 | 0.78 | 118.55 | 68.44 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -17.22 | -31.87 | 12.37 | -21.54 | 1.7 | 28.26 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -38.05 | -43.64 | -41.42 | -64.43 | -76.27 | -40.18 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -69183.64% | -198363.64% | - | -2515.93% | -1779.51% | -1455.20% |
Free Cash Flow Per Share | -1.31 | -1.94 | -9.01 | -14.52 | -29.21 | -137.96 |
Levered Free Cash Flow | -17.11 | -23.34 | -3.52 | -75.14 | -57.23 | -17.92 |
Unlevered Free Cash Flow | -17.11 | -23.34 | -3.52 | -75.14 | -57.23 | -17.92 |